Get started
Author

Mary A. Bewick

Observed names: M Bewick, M. A. Bewick, M. Bewick, Mary A Bewick, Mary Bewick
OpenAlex ID: A5042833263
The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity
2004 · R Syme, M Bewick, et al. · Transplantation and Cellular Therapy · 125
Polymorphisms inXRCC1,XRCC3, andCCND1and Survival After Treatment for Metastatic Breast Cancer
2006 · Mary A. Bewick, Michael S.C. Conlon, et al. · Journal of Clinical Oncology · 79
PDF
Evaluation of three rapid RNA extraction reagents: relevance for use in RT-PCR's and measurement of low level gene expression in clinical samples.
1997 · T Chadderton, C Wilson, et al. · PubMed · 60
Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer
2010 · Michael S.C. Conlon, Kenneth C. Johnson, et al. · Cancer Epidemiology · 39
Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer
2007 · Mary A. Bewick, Michael S. C. Conlon, et al. · Breast Cancer Research and Treatment · 37
Soluble Fas (CD95) Is a Prognostic Factor in Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation
2001 · M. Bewick, M. Conlon, et al. · Stem Cells and Development · 35
HER-2 expression is a prognostic factor in patients with metastatic breast cancer treated with a combination of high-dose cyclophosphamide, mitoxantrone, paclitaxel and autologous blood stem cell support
2001 · M Bewick, M Conlon, et al. · Bone Marrow Transplantation · 31
Single Nucleotide Polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 Are Associated With Heaviness of Smoking in Women in Northeastern Ontario, Canada
2011 · M. S. Conlon, M. A. Bewick · Nicotine & Tobacco Research · 27
HSG cells differentiated by culture on extracellular matrix involves induction of S‐adenosylmethione decarboxylase and ornithine decarboxylase
2004 · Kirby Lam, Lianfeng Zhang, et al. · Journal of Cellular Physiology · 27
Adhesion Dependent Signalling in the Tumour Microenvironment: The Future of Drug Targetting
2006 · Mary Bewick, Robert Lafrenie · Current Pharmaceutical Design · 25
Cell adhesion and cancer: is there a potential for therapeutic intervention?
2007 · Robert M Lafrenie, Carly A Buckner, et al. · Expert Opinion on Therapeutic Targets · 24
Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support
1999 · M Bewick, T Chadderton, et al. · Bone Marrow Transplantation · 24
Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer
2010 · Mary A. Bewick, Robert M. Lafrenie, et al. · Journal of Cancer Research and Clinical Oncology · 22
Evaluation of sICAM-1, sVCAM-1, and sE-Selectin Levels in Patients with Metastatic Breast Cancer Receiving High-Dose Chemotherapy
2004 · M. Bewick, M. Conlon, et al. · Stem Cells and Development · 19
A case–control study of breast cancer risk in nurses from Northeastern Ontario, Canada
2015 · Stacey A. Santi, Margaret L. Meigs, et al. · Cancer Causes & Control · 11
EGFR and ErbB2 Differentially Regulate Raf-1 Translocation and Activation
2002 · Lianfeng Zhang, Mary Bewick, et al. · Laboratory Investigation · 11
PDF
Plasma Cytokine Levels and Cytokine Genetic Polymorphisms in Patients with Metastatic Breast Cancer Receiving High-Dose Chemotherapy
2023 · Robert Lafrenie, Mary Bewick, et al. · Immuno · 4
PDF
Expression of C-Erb B-2/Her-2 in Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy and Autologous Blood Stem Cell Support
1999 · M. Bewick, T. Chadderton, et al. · Springer eBooks · 4
Haplotypes of XRCC1 and survival outcome in patients with metastatic breast cancer
2009 · Mary A. Bewick, Michael S. C. Conlon, et al. · Breast Cancer Research and Treatment · 3
Abstract 4141: Access to medical or radiation oncology consultation in patients who died from cancer in the Sudbury-Manitoulin District of Northeastern Ontario, Canada
2014 · Michael Conlon, Mark Hartman, et al. · Cancer Research
Abstract 1336: A population-based study of Transforming Growth Factor-Beta1 (TGFB1) polymorphisms and risk of breast cancer.
2013 · Mary A. Bewick, Michael SC Conlon · Cancer Research
Abstract 4453: Smoking characteristics, intention to quit, and nicotine dependence in patients with head and neck cancer
2012 · Michael S.C. Conlon, Deborah P. Saunders, et al. · Cancer Research
Abstract 2756: Heavy smoking in Northeastern Ontario women is associated with polymorphisms in nicotinic acetylcholine receptor genes
2011 · Mary A. Bewick, Michael S.C. Conlon · Cancer Research
Abstract 1865: ERCC2 polymorphisms, smoking, and risk of breast cancer
2010 · Michael S. Conlon, Mary A. Bewick · Cancer Research
Smoking (Passive and Active), N-Acetyl-Transferase 2 (Nat2), and Risk of Breast Cancer
2006 · M Conlon, K Johnson, et al. · American Journal of Epidemiology
Works count: 26
Citation count: 607
H-index: 14
I10-index: 16
Year
Topic
Type